Your browser doesn't support javascript.
loading
RBM24 suppresses cancer progression by upregulating miR-25 to target MALAT1 in nasopharyngeal carcinoma.
Hua, Wen-Feng; Zhong, Qian; Xia, Tian-Liang; Chen, Qi; Zhang, Mei-Yin; Zhou, Ai-Jun; Tu, Zi-Wei; Qu, Chen; Li, Man-Zhi; Xia, Yun-Fei; Wang, Hui-Yun; Xie, Dan; Claret, Francois-Xavier; Song, Er-Wei; Zeng, Mu-Sheng.
Afiliação
  • Hua WF; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Zhong Q; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Xia TL; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Chen Q; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Zhang MY; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Zhou AJ; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Tu ZW; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Qu C; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Li MZ; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Xia YF; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Wang HY; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Xie D; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Claret FX; Department of Systems Biology, University of Texas-MD Anderson Cancer Center, Houston, TX, USA.
  • Song EW; Breast Cancer Center of Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Zeng MS; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
Cell Death Dis ; 7(9): e2352, 2016 09 01.
Article em En | MEDLINE | ID: mdl-27584791
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma / Regulação Neoplásica da Expressão Gênica / Regulação para Cima / Neoplasias Nasofaríngeas / Proteínas de Ligação a RNA / Progressão da Doença / MicroRNAs / RNA Longo não Codificante Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Cell Death Dis Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma / Regulação Neoplásica da Expressão Gênica / Regulação para Cima / Neoplasias Nasofaríngeas / Proteínas de Ligação a RNA / Progressão da Doença / MicroRNAs / RNA Longo não Codificante Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Cell Death Dis Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China